ClinicalTrials.gg
RecruitingNCT05034835VECODONUpdated Oct 6, 2025

Impact of Compression Garments on Pain in Patients With Complex Regional Pain Syndrome of the Upper Limbs.

An interventional study of usual treatment with compression garments (CERECARE) and usual treatment without compression garments (CERECARE) in Complex Regional Pain Syndromes, sponsored by Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-06.

Sponsored by Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Oct 2021; still recruiting 5 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim is to study another alternative for the treatment of pain in people with CRPS. Indeed, the TRAB / Medullary occupational therapy department of the CMRRF in Kerpape used compression garments to reduce edema when it was present.In the case of CRPS of the upper limbs, gloves or compression sleeves are used to decrease the edema which is sometimes associated, although they are not supported for this indication. In this context, our clinical experience leads us to believe that there would also be some efficacy in neuropathic pain, this improvement being regularly described by patients.This study is expected to show a notable reduction in neuropathic pain thanks to the wearing of a compression garment.

02

Conditions studied

  • Complex Regional Pain Syndromes
03

In context

Complex Regional Pain Syndromes

205 studies on the registry are indexed under Complex Regional Pain Syndromes; 55 are open to participants now.

This study's planned enrollment of 60 is above the median of 40 across 152 interventional studies indexed under Complex Regional Pain Syndromes.

Browse Complex Regional Pain Syndromes studies →

Lead sponsor

Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape is the lead sponsor of 10 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with CRPS of the upper limb with neuropathic pain

    • Diagnosis of CRPS according to the Budapest criteria
    • Diagnosis of neuropathic pain according to DN4
  • CRPS evolving for more than 3 months
  • No phlebitis or open sores on the upper limbs
  • Patient consent to participate in the study
  • No modification of his drug treatment for 1 month
  • Affiliation to a social security scheme or beneficiary of such a scheme

Exclusion criteria

Exclusion Criteria:

  • Patient under guardianship, curatorship or safeguard of justice
  • Psychiatric pathology altering the ability to consent
  • Severe cognitive disorders that do not allow the patient to assess his pain
  • Skin pathology preventing the wearing of the compression garment
  • Patient who has previously worn a compression garment
  • History of vascular disorders of the upper limbs, lymph node dissection, or any other pathology that can lead to edema regardless of CRPS
  • Known allergy to one of the components of the compression garments of the Cerecare brand
  • Declared pregnancy, breastfeeding woman or woman of without
  • Inability to put on the compression garment alone
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    With compression garments

    Usual care in day hospitals, i.e. 3 occupational therapy sessions / week for 3 months, with the usual protocol of desensitization by Aquaroll (hydro-massage ball device) and by Vibralgic (device generating electronic transcutaneous vibrations) + wearing a compression garment for 3 months.

    Device: usual treatment with compression garments (CERECARE)

  • Other
    Without compression garments

    Usual care in day hospitals, i.e. 3 occupational therapy sessions / week for 3 months, with the usual protocol of desensitization by Aquaroll (hydro-massage ball device) and by Vibralgic (device generating electronic transcutaneous vibrations).

    Other: usual treatment without compression garments (CERECARE)

Interventions

  • Deviceusual treatment with compression garments (CERECARE)

    For 3 months, the pain will be assessed every week, tolerance and compliance with compression garments will also be monitored. Participants will be reviewed specifically at a follow-up consultation for the 6-month and 1-year study. Various assessments will be carried out during these visits : assessment of pain, range of motion, muscle strength, sensitivity test, assessment of anxiety, depression and even quality of life.

  • Otherusual treatment without compression garments (CERECARE)

    For 3 months, the pain will be assessed every week, tolerance and compliance with compression garments will also be monitored. Participants will be reviewed specifically at a follow-up consultation for the 6-month and 1-year study. Various assessments will be carried out during these visits : assessment of pain, range of motion, muscle strength, sensitivity test, assessment of anxiety, depression and even quality of life.

06

What researchers measure

Primary outcomes

  1. The evolution of pain through Visual Analog Scale (VAS), measured every week for 3 months in the last 24 hours and in the last 7 days

    The VAS is a self-rated scale. It comes in the form of a 10 cm plastic ruler graduated in mm. On the face presented to the patient is a cursor which he moves along a straight line, one end of which corresponds to "No pain" and the other to "Maximum pain imaginable". The patient should, along this line, position the cursor where the pain is best located. On the other side, there are millimeter graduations seen only by the caregiver. The position of the cursor mobilized by the patient makes it possible to read the intensity of the pain, which is measured in mm.

    Time frame: up to 3 months

Secondary outcomes

  1. Visual Analog Scale (VAS)

    The VAS is a self-rated scale. It comes in the form of a 10 cm plastic ruler graduated in mm. On the face presented to the patient is a cursor which he moves along a straight line, one end of which corresponds to "No pain" and the other to "Maximum pain imaginable". The patient should, along this line, position the cursor where the pain is best located. On the other side, there are millimeter graduations seen only by the caregiver. The position of the cursor mobilized by the patient makes it possible to read the intensity of the pain, which is measured in mm.

    Time frame: At 6 months

  2. Visual Analog Scale (VAS)

    The VAS is a self-rated scale. It comes in the form of a 10 cm plastic ruler graduated in mm. On the face presented to the patient is a cursor which he moves along a straight line, one end of which corresponds to "No pain" and the other to "Maximum pain imaginable". The patient should, along this line, position the cursor where the pain is best located. On the other side, there are millimeter graduations seen only by the caregiver. The position of the cursor mobilized by the patient makes it possible to read the intensity of the pain, which is measured in mm.

    Time frame: At 1 year

  3. Neuropathic Pain Symptom Inventory (NPSI)

    It's a tool developed and validated in French, composed of 12 items. It provides an overall score and 5 sub-scores

    Time frame: Day 0

  4. Neuropathic Pain Symptom Inventory (NPSI)

    It's a tool developed and validated in French, composed of 12 items. It provides an overall score and 5 sub-scores

    Time frame: At 1,5 months

  5. Neuropathic Pain Symptom Inventory (NPSI)

    It's a tool developed and validated in French, composed of 12 items. It provides an overall score and 5 sub-scores

    Time frame: At 3 months

  6. Neuropathic Pain Symptom Inventory (NPSI)

    It's a tool developed and validated in French, composed of 12 items. It provides an overall score and 5 sub-scores

    Time frame: At 6 months

  7. Neuropathic Pain Symptom Inventory (NPSI)

    It's a tool developed and validated in French, composed of 12 items. It provides an overall score and 5 sub-scores

    Time frame: At 1 year

  8. Modification of analgesic drug treatment

    The increase or decrease in doses between each visit will be collected by the doctor. He can rely on the booklet filled out by the patient.

    Time frame: Day 0

  9. Modification of analgesic drug treatment

    The increase or decrease in doses between each visit will be collected by the doctor. He can rely on the booklet filled out by the patient.

    Time frame: At 1,5 months

  10. Modification of analgesic drug treatment

    The increase or decrease in doses between each visit will be collected by the doctor. He can rely on the booklet filled out by the patient.

    Time frame: At 3 months

  11. Modification of analgesic drug treatment

    The increase or decrease in doses between each visit will be collected by the doctor. He can rely on the booklet filled out by the patient.

    Time frame: At 6 months

  12. Modification of analgesic drug treatment

    The increase or decrease in doses between each visit will be collected by the doctor. He can rely on the booklet filled out by the patient.

    Time frame: At 1 year

  13. Measurement of range of motion

    The range of motion is measured exploratory at different levels, for both sides: * Wrist range of motion, measured using posture foam and goniometer. This measures the amplitude in flexion, extension, radial tilt, ulnar tilt, and pronation and supination, both passively and actively. * Pulp-palm and pulp palmar fold distances of the fingers, measured using wedges of different lengths. One measurement is made per finger * Kapandji score, which is a score out of 10 based on achievable opposition for the thumb. 0 being the lowest score and 10 a normal score.

    Time frame: Day 0

  14. Measurement of range of motion

    The range of motion is measured exploratory at different levels, for both sides: * Wrist range of motion, measured using posture foam and goniometer. This measures the amplitude in flexion, extension, radial tilt, ulnar tilt, and pronation and supination, both passively and actively. * Pulp-palm and pulp palmar fold distances of the fingers, measured using wedges of different lengths. One measurement is made per finger * Kapandji score, which is a score out of 10 based on achievable opposition for the thumb. 0 being the lowest score and 10 a normal score.

    Time frame: At 1,5 months

  15. Measurement of range of motion

    The range of motion is measured exploratory at different levels, for both sides: * Wrist range of motion, measured using posture foam and goniometer. This measures the amplitude in flexion, extension, radial tilt, ulnar tilt, and pronation and supination, both passively and actively. * Pulp-palm and pulp palmar fold distances of the fingers, measured using wedges of different lengths. One measurement is made per finger * Kapandji score, which is a score out of 10 based on achievable opposition for the thumb. 0 being the lowest score and 10 a normal score.

    Time frame: At 3 months

  16. Measurement of range of motion

    The range of motion is measured exploratory at different levels, for both sides: * Wrist range of motion, measured using posture foam and goniometer. This measures the amplitude in flexion, extension, radial tilt, ulnar tilt, and pronation and supination, both passively and actively. * Pulp-palm and pulp palmar fold distances of the fingers, measured using wedges of different lengths. One measurement is made per finger * Kapandji score, which is a score out of 10 based on achievable opposition for the thumb. 0 being the lowest score and 10 a normal score.

    Time frame: At 6 months

  17. Measurement of range of motion

    The range of motion is measured exploratory at different levels, for both sides: * Wrist range of motion, measured using posture foam and goniometer. This measures the amplitude in flexion, extension, radial tilt, ulnar tilt, and pronation and supination, both passively and actively. * Pulp-palm and pulp palmar fold distances of the fingers, measured using wedges of different lengths. One measurement is made per finger * Kapandji score, which is a score out of 10 based on achievable opposition for the thumb. 0 being the lowest score and 10 a normal score.

    Time frame: At 1 year

  18. Measurement of muscle strength in both hands

    * the JAMAR® hydraulic hand dynamometer: measurement of the gripping force in kilograms * the PINCH® hydraulic pinch gauge: measures the pinch force in kilograms

    Time frame: Day 0

  19. Measurement of muscle strength in both hands

    * the JAMAR® hydraulic hand dynamometer: measurement of the gripping force in kilograms * the PINCH® hydraulic pinch gauge: measures the pinch force in kilograms

    Time frame: At 1,5 months

  20. Measurement of muscle strength in both hands

    * the JAMAR® hydraulic hand dynamometer: measurement of the gripping force in kilograms * the PINCH® hydraulic pinch gauge: measures the pinch force in kilograms

    Time frame: At 3 months

  21. Measurement of muscle strength in both hands

    * the JAMAR® hydraulic hand dynamometer: measurement of the gripping force in kilograms * the PINCH® hydraulic pinch gauge: measures the pinch force in kilograms

    Time frame: At 6 months

  22. Measurement of muscle strength in both hands

    * the JAMAR® hydraulic hand dynamometer: measurement of the gripping force in kilograms * the PINCH® hydraulic pinch gauge: measures the pinch force in kilograms

    Time frame: At 1 year

  23. Measurement of hand circumference

    The circumference of the hand is measured in different places. A total of 15 measurements are taken. Both hands are measured. The analysis will be based on the difference of the sum of the 15 measures for each of the hands.

    Time frame: Day 0

  24. Measurement of hand circumference

    The circumference of the hand is measured in different places. A total of 15 measurements are taken. Both hands are measured. The analysis will be based on the difference of the sum of the 15 measures for each of the hands.

    Time frame: At 1,5 months

  25. Measurement of hand circumference

    The circumference of the hand is measured in different places. A total of 15 measurements are taken. Both hands are measured. The analysis will be based on the difference of the sum of the 15 measures for each of the hands.

    Time frame: At 3 months

  26. Measurement of hand circumference

    The circumference of the hand is measured in different places. A total of 15 measurements are taken. Both hands are measured. The analysis will be based on the difference of the sum of the 15 measures for each of the hands.

    Time frame: At 6 months

  27. Measurement of hand circumference

    The circumference of the hand is measured in different places. A total of 15 measurements are taken. Both hands are measured. The analysis will be based on the difference of the sum of the 15 measures for each of the hands.

    Time frame: At 1 year

  28. Saint-Antoine Pain Questionnaire (QDSA)

    Illustrating the different components of pain, the QDSA (French version of the Mac Gill Pain Questionnary-MPQ) essentially allows a qualitative assessment of chronic pain, in particular neuropathic pain. It is a questionnaire of 58 qualifying words divided into subclasses: sensory pain on the one hand, affective and emotional pain on the other. The patient is asked to select the adjectives corresponding to his pain and then to note them from 0 (absent) to 4 (very strong). This self-assessment scale makes it possible in clinical practice to specify the involvement of the sensory and the emotional in pain intensity.

    Time frame: Day 0

  29. Saint-Antoine Pain Questionnaire (QDSA)

    Illustrating the different components of pain, the QDSA (French version of the Mac Gill Pain Questionnary-MPQ) essentially allows a qualitative assessment of chronic pain, in particular neuropathic pain. It is a questionnaire of 58 qualifying words divided into subclasses: sensory pain on the one hand, affective and emotional pain on the other. The patient is asked to select the adjectives corresponding to his pain and then to note them from 0 (absent) to 4 (very strong). This self-assessment scale makes it possible in clinical practice to specify the involvement of the sensory and the emotional in pain intensity.

    Time frame: At 1,5 months

  30. Saint-Antoine Pain Questionnaire (QDSA)

    Illustrating the different components of pain, the QDSA (French version of the Mac Gill Pain Questionnary-MPQ) essentially allows a qualitative assessment of chronic pain, in particular neuropathic pain. It is a questionnaire of 58 qualifying words divided into subclasses: sensory pain on the one hand, affective and emotional pain on the other. The patient is asked to select the adjectives corresponding to his pain and then to note them from 0 (absent) to 4 (very strong). This self-assessment scale makes it possible in clinical practice to specify the involvement of the sensory and the emotional in pain intensity.

    Time frame: At 3 months

  31. Saint-Antoine Pain Questionnaire (QDSA)

    Illustrating the different components of pain, the QDSA (French version of the Mac Gill Pain Questionnary-MPQ) essentially allows a qualitative assessment of chronic pain, in particular neuropathic pain. It is a questionnaire of 58 qualifying words divided into subclasses: sensory pain on the one hand, affective and emotional pain on the other. The patient is asked to select the adjectives corresponding to his pain and then to note them from 0 (absent) to 4 (very strong). This self-assessment scale makes it possible in clinical practice to specify the involvement of the sensory and the emotional in pain intensity.

    Time frame: At 6 months

  32. Saint-Antoine Pain Questionnaire (QDSA)

    Illustrating the different components of pain, the QDSA (French version of the Mac Gill Pain Questionnary-MPQ) essentially allows a qualitative assessment of chronic pain, in particular neuropathic pain. It is a questionnaire of 58 qualifying words divided into subclasses: sensory pain on the one hand, affective and emotional pain on the other. The patient is asked to select the adjectives corresponding to his pain and then to note them from 0 (absent) to 4 (very strong). This self-assessment scale makes it possible in clinical practice to specify the involvement of the sensory and the emotional in pain intensity.

    Time frame: At 1 year

  33. Cartographic assessment of pain

    The cartographic assessment of pain is carried out following the QDSA. Using schematic representations of the hand (dorsal face and palmar face for each hand), the patient locates and describes his pain.

    Time frame: Day 0

  34. Cartographic assessment of pain

    The cartographic assessment of pain is carried out following the QDSA. Using schematic representations of the hand (dorsal face and palmar face for each hand), the patient locates and describes his pain.

    Time frame: At 1,5 months

  35. Cartographic assessment of pain

    The cartographic assessment of pain is carried out following the QDSA. Using schematic representations of the hand (dorsal face and palmar face for each hand), the patient locates and describes his pain.

    Time frame: At 3 months

  36. Cartographic assessment of pain

    The cartographic assessment of pain is carried out following the QDSA. Using schematic representations of the hand (dorsal face and palmar face for each hand), the patient locates and describes his pain.

    Time frame: At 6 months

  37. Cartographic assessment of pain

    The cartographic assessment of pain is carried out following the QDSA. Using schematic representations of the hand (dorsal face and palmar face for each hand), the patient locates and describes his pain.

    Time frame: At 1 year

  38. Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire

    This is a subjective self-assessment questionnaire of the overall functional capacity of the two upper limbs, composed of 30 items, rated from 1 to 5 depending on the difficulty of the task described, leading to a score out of 100.

    Time frame: Day 0

  39. Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire

    This is a subjective self-assessment questionnaire of the overall functional capacity of the two upper limbs, composed of 30 items, rated from 1 to 5 depending on the difficulty of the task described, leading to a score out of 100.

    Time frame: At 1,5 months

  40. Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire

    This is a subjective self-assessment questionnaire of the overall functional capacity of the two upper limbs, composed of 30 items, rated from 1 to 5 depending on the difficulty of the task described, leading to a score out of 100.

    Time frame: At 3 months

  41. Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire

    This is a subjective self-assessment questionnaire of the overall functional capacity of the two upper limbs, composed of 30 items, rated from 1 to 5 depending on the difficulty of the task described, leading to a score out of 100.

    Time frame: At 6 months

  42. Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire

    This is a subjective self-assessment questionnaire of the overall functional capacity of the two upper limbs, composed of 30 items, rated from 1 to 5 depending on the difficulty of the task described, leading to a score out of 100.

    Time frame: At 1 year

  43. Hospital Anxiety and Depression (HAD) Scale

    It comprises 14 items, allowing the obtaining of 2 scores out of 21 points, corresponding to the dimensions of anxiety and depression

    Time frame: Day 0

  44. Hospital Anxiety and Depression (HAD) Scale

    It comprises 14 items, allowing the obtaining of 2 scores out of 21 points, corresponding to the dimensions of anxiety and depression

    Time frame: At 1,5 months

  45. Hospital Anxiety and Depression (HAD) Scale

    It comprises 14 items, allowing the obtaining of 2 scores out of 21 points, corresponding to the dimensions of anxiety and depression

    Time frame: At 3 months

  46. Hospital Anxiety and Depression (HAD) Scale

    It comprises 14 items, allowing the obtaining of 2 scores out of 21 points, corresponding to the dimensions of anxiety and depression

    Time frame: At 6 months

  47. Hospital Anxiety and Depression (HAD) Scale

    It comprises 14 items, allowing the obtaining of 2 scores out of 21 points, corresponding to the dimensions of anxiety and depression

    Time frame: At 1 year

  48. The Short Form (36) Health Survey

    This is a standardized test for measuring the quality of life. It includes 36 items divided into 8 dimensions (physical functioning, role limitations related to physical health, physical pain, general health, vitality \[energy / fatigue\], functioning or social well-being, role limitations related to mental health, Mental Health).

    Time frame: Day 0

  49. The Short Form (36) Health Survey

    This is a standardized test for measuring the quality of life. It includes 36 items divided into 8 dimensions (physical functioning, role limitations related to physical health, physical pain, general health, vitality \[energy / fatigue\], functioning or social well-being, role limitations related to mental health, Mental Health).

    Time frame: At 1,5 months

  50. The Short Form (36) Health Survey

    This is a standardized test for measuring the quality of life. It includes 36 items divided into 8 dimensions (physical functioning, role limitations related to physical health, physical pain, general health, vitality \[energy / fatigue\], functioning or social well-being, role limitations related to mental health, Mental Health).

    Time frame: At 3 months

  51. The Short Form (36) Health Survey

    This is a standardized test for measuring the quality of life. It includes 36 items divided into 8 dimensions (physical functioning, role limitations related to physical health, physical pain, general health, vitality \[energy / fatigue\], functioning or social well-being, role limitations related to mental health, Mental Health).

    Time frame: At 6 months

  52. The Short Form (36) Health Survey

    This is a standardized test for measuring the quality of life. It includes 36 items divided into 8 dimensions (physical functioning, role limitations related to physical health, physical pain, general health, vitality \[energy / fatigue\], functioning or social well-being, role limitations related to mental health, Mental Health).

    Time frame: At 1 year

  53. Observance of wearing the compression garment

    Compliance with the wearing of the compression garment will be measured by the average number of hours of wearing the garment per day, which will be evaluated on the patient's statements in the experimental arm during the visits.

    Time frame: Every week for 3 months

  54. Tolerance of wearing the compression garment

    The tolerance of wearing the compression garment will be assessed by recording the presence of irritation or surface skin lesion, compression felt as being too unpleasant or even unbearable by the patient in the experimental arm and leading to stopping wearing.

    Time frame: Every week for 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2021 (actual). Primary completion is estimated for May 2026, 55 months after the start.

Of 64 non-industry interventional studies with no phase under Complex Regional Pain Syndromes, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 60. This study's planned 55 months is above that.

Counting every sponsor, half of 65 studies reached it within 24 months; a quarter within 14 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 26, 2021
First posted
Sep 5, 2021
StartActual
Oct 12, 2021
Primary completionEst.
May 2026
CompletionEst.
Oct 2026
Last update
Oct 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05034835
Lead sponsor
Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape
Collaborators
Clinique Mutualiste Lorient, Fondation Rothschild Paris, Groupement des Hôpitaux de l'Institut Catholique de Lille
Responsible party
Sponsor
First posted
Sep 5, 2021
Start date
Oct 12, 2021
Primary completion
May 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Oct 6, 2025

Study contacts

Vincent Detaille, Doctor
Contact
vincent.detaille@vyv3.fr
02 97 82 60 28 ext. +33
Marie-Caroline Delebecque, CRA
Contact
kerpape.arc@vyv3.fr
02 97 82 62 93 ext. +33
Vincent Detaille, Doctor
principal investigator · CMRRF de Kerpape

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion